| MR-guidance in clinical reality: current treatment challenges and future perspectives S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ... Radiation Oncology 14 (1), 92, 2019 | 392 | 2019 |
| Current status and recent advances in reirradiation of glioblastoma G Minniti, M Niyazi, F Alongi, P Navarria, C Belka Radiation Oncology 16 (1), 36, 2021 | 244 | 2021 |
| Review and uses of stereotactic body radiation therapy for oligometastases F Alongi, S Arcangeli, AR Filippi, U Ricardi, M Scorsetti The oncologist 17 (8), 1100-1107, 2012 | 244 | 2012 |
| Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial M Scorsetti, S Arcangeli, A Tozzi, T Comito, F Alongi, P Navarria, ... International Journal of Radiation Oncology* Biology* Physics 86 (2), 336-342, 2013 | 226 | 2013 |
| Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique R Ruggieri, S Naccarato, R Mazzola, F Ricchetti, S Corradini, A Fiorentino, ... Radiation Oncology 13 (1), 38, 2018 | 197 | 2018 |
| Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non … P Navarria, AM Ascolese, P Mancosu, F Alongi, E Clerici, A Tozzi, C Iftode, ... Radiotherapy and Oncology 107 (3), 414-418, 2013 | 197 | 2013 |
| Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO … SGC Kroeze, M Pavic, K Stellamans, Y Lievens, C Becherini, M Scorsetti, ... The lancet oncology 24 (3), e121-e132, 2023 | 191 | 2023 |
| Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial M Trovo, C Furlan, J Polesel, F Fiorica, S Arcangeli, N Giaj-Levra, ... Radiotherapy and Oncology 126 (1), 177-180, 2018 | 185 | 2018 |
| Neuroendocrine carcinoma of the breast: current evidence and future perspectives A Inno, G Bogina, M Turazza, L Bortesi, S Duranti, A Massocco, ... The oncologist 21 (1), 28-32, 2016 | 166 | 2016 |
| IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy F Alongi, C Fiorino, C Cozzarini, S Broggi, L Perna, GM Cattaneo, ... Radiotherapy and Oncology 93 (2), 207-212, 2009 | 165 | 2009 |
| Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study L Triggiani, F Alongi, M Buglione, B Detti, R Santoni, A Bruni, ... British journal of cancer 116 (12), 1520-1525, 2017 | 163 | 2017 |
| Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body … E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ... European urology 76 (6), 732-739, 2019 | 154 | 2019 |
| Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases S Corradini, D Reitz, M Pazos, S Schönecker, M Braun, N Harbeck, ... Cancers 11 (2), 160, 2019 | 151 | 2019 |
| Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments M Scorsetti, F Alongi, S Castiglioni, A Clivio, A Fogliata, F Lobefalo, ... Radiation oncology 6 (1), 113, 2011 | 150 | 2011 |
| 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra, L Nicosia, F Ricchetti, ... Radiation Oncology 15 (1), 69, 2020 | 136 | 2020 |
| Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study F Alongi, L Cozzi, S Arcangeli, C Iftode, T Comito, E Villa, F Lobefalo, ... Radiation Oncology 8 (1), 171, 2013 | 128 | 2013 |
| Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments P Navarria, AM Ascolese, S Tomatis, L Cozzi, F De Rose, P Mancosu, ... Radiation Oncology 9 (1), 91, 2014 | 124 | 2014 |
| SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience A Tozzi, T Comito, F Alongi, P Navarria, C Iftode, P Mancosu, G Reggiori, ... Radiation Oncology 8 (1), 148, 2013 | 122 | 2013 |
| Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer C Cozzarini, C Fiorino, N Di Muzio, F Alongi, S Broggi, M Cattaneo, ... Radiotherapy and oncology 84 (2), 164-170, 2007 | 117 | 2007 |
| Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of … M Scorsetti, F Alongi, A Fogliata, S Pentimalli, P Navarria, F Lobefalo, ... Radiation oncology 7 (1), 145, 2012 | 116 | 2012 |
Alba FiorentinoRadiation Oncology Sacro Cuore Hospital, Negrar (VR) ItalyVerified email at sacrocuore.it
